Callan Capital, LLC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 26 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Callan Capital, LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,998
-27.7%
20,0000.0%0.00%
-50.0%
Q2 2023$16,604
+135.4%
20,0000.0%0.00%
+100.0%
Q1 2023$7,054
-17.5%
20,0000.0%0.00%0.0%
Q4 2022$8,552
-22.3%
20,0000.0%0.00%
-50.0%
Q3 2022$11,000
-60.7%
20,0000.0%0.00%
-50.0%
Q2 2022$28,00020,0000.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders